| 摘要 |
<p>Vital tissue-protecting agents whereby deterioration in organs for transplantation, etc. can be prevented, in particular, novel cornea-protecting agents for preventing or treating various eye diseases in association with corneal endothelium failure or corneal parenchymatous failure. These vital tissue-protecting agents contain a protease inhibitor as the active ingredient and have an effect of protecting vital tissues.</p> |
